Abstract:Poster session 2, September 22, 2022, 12:30 PM - 1:30 PMObjective: We present ten tinea incognito (TI) patients caused by Trichophyton rubrum combined with a review of the characteristics of tinea incognito infections reported worldwide over the past 20 years, leading to clinical requirements for diagnosis and treatment.Patients and Methods: Patients were scraped for direct KOH microscopy of the skin lesions at the initial visit, isolates were cultured in SDA medium for 14 days and species were identified by morphology and molecular analysis using ITS regions. Literature review by searching articles on 'PubMed' and 'Web of Science', using the keywords 'Tinea incognito or Incognito', Set the year as '2002-2022', and screened the literature for cases with clear types of TI infecting pathogens. Clinical, mycological, and treatment data of all cases were collected and analyzed.ResultsWe report 10 cases of tinea incognito caused by T. rubrum, ranging in age from 5 to 70 years, with clinical manifestations of eczema-like (Figs. 1a, b, and f), SLE-like (Fig. 1d) and pustular psoriasis-like (Figure 1c, e, g, h, i and j), seen in multiple sites. All of our patients had either tinea pedis or onychomycosis themselves or in their family members.A total of 660 cases reported in the last 20 years, T. rubrum (279/660) was the main anthropophilic dermatophytes causing TI, T. mentagrophytes (162/660) and Microsporum canis (135/660) were the common zoophilic pathgens. There were median age differences in patients infected with T. rubrum, T. mentagrophytes, M. canis, and Nannizzia gypsea , at 56, 22.5, 23, and 5.5 years old, respectively (Fig. 2a). The TI patients infected by T. rubrum often had cutaneous or non-cutaneous underlying diseases (27/41), TI patients with zoophilic or geophilic dermatophyte infections had a definite animal or soil contact history (114/136). The face and trunk are the most frequently affected areas, followed by the extremities and the whole body (Fig. 2b). TI appears on the face and is often thought of as eczema, rosacea, DLE, photosensitive rash, and when it occurs on the trunk is misdiagnosed as eczema, pyoderma, psoriasis (Fig. 2c). In Asia and the Americas, anthropophilic dermatophytes are by far the most reported pathogens, especially T. rubrum. In Europe, zoonotic pathogens have been reported in excess of the anthropophilic (Fig. 2d). For patients in whom the nature of the lesions cannot be determined and with negative direct microscopic examination, dermoscopy can be used to aid in the diagnosis. Our review of all cases found that topical or systemic antifungal treatment always gave good efficacy.ConclusionTI has a broad spectrum of mimics, and an unrestricted range of target audiences, zoonotic pathogens are adapting to the human host, so the history of illness and contact is essential at the time of the initial visit. A definitive diagnosis must be obtained in a mycological laboratory, multiple modalities can be used to diagnose TI, and systemic antifungal treatment is often necessary.

Trichophyton indotineae

[Persistent dermatomycosis due toTrichophyton indotineae]

Spread of Terbinafine-Resistant Trichophyton mentagrophytes Type VIII (India) in Germany–“The Tip of the Iceberg?”

GD04 Erythroderma: uncovering the culprit

Terbinafine Resistant Trichophyton Indotineae Isolated in Patients with Superficial Dermatophyte Infection in Canadian Patients

First Reported Cases of Terbinafine‐Resistant Trichophyton indotineae Isolates in Israel: Epidemiology, Clinical Characteristics and Response to Treatment

Recalcitrant dermatophyte infections: identification and risk factors

Antifungal Resistance, Susceptibility Testing and Treatment of Recalcitrant Dermatophytosis Caused by Trichophyton indotineae: A North American Perspective on Management

Genomic epidemiology of emerging terbinafine-resistant Trichophyton indotineae

Terbinafine-resistant Trichophyton indotineae causing extensive dermatophytosis in a returning traveller, London, United Kingdom

Trichophyton indotineae sp. nov.: A New Highly Terbinafine-Resistant Anthropophilic Dermatophyte Species

The Domestic Isolation of Terbinafine- and Itraconazole-Resistant Trichophyton indotineae in Chinese Mainland

Rapid emergence of recalcitrant dermatophytosis caused by a cluster of multidrug-resistant Trichophyton indotineae in China

Antifungal resistance in dermatophytes – review of the epidemiology, diagnostic challenges and treatment strategies for managing Trichophyton indotineae infections

Resistance Profile, Terbinafine Resistance Screening and MALDI-TOF MS Identification of the Emerging Pathogen Trichophyton indotineae

Mapping the Global Spread of T. indotineae: An Update on Antifungal Resistance, Mutations, and Strategies for Effective Management

Clinico-mycological and therapeutic updates on tinea corporis/cruris in the era of Trichophyton indotineae

A systematic review on the emergence of terbinafine-resistant Trichophyton indotineae in Europe: Time to act?

Terbinafine-Resistant Dermatophytes and the Presence of Trichophyton indotineae in North America

A Review of the Treatment Options

P320 Ten cases of tinea incognito due to Trichophyton rubrum, and literature review on the pathogenic characteristics